Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Anupam Rasayan India Earnings Call: Key Takeaways

Anupam Rasayan announced the acquisition of Bliss GVS Pharma (43.3-48.2% stake plus open offer) to expand into pharmaceutical formulations and regulated markets like the USA.

Highlights
Revenue growthFY26 Revenue ₹927cr, growing from ₹810cr in FY25.
MarginsEBITDA margins improved from 16% to 18% in FY26.
Demand visibilitySupported by long-standing distributor relationships and 150+ brands.
Management confidenceStrong focus on synergies and USA footprint expansion.

Growth

Bliss GVS FY26 Revenue at ₹927cr (14.4% YoY), EBITDA ₹164cr (18% margin), and PAT ₹135cr (50% YoY).

Outlook

Ongoing Capex of ₹250cr for Halol facility; targeting entry into regulated markets with a pipeline of 62+ molecules.

Risks

Low capacity utilization (currently 30%); expansion depends on successful integration and penetration of highly regulated Western markets.

Source

Earnings Call filed with BSE, NSE: ANURAS. Summary written with AI assistance from the document.

Read the document ↗

Anupam Rasayan India Ltd: key numbers

Share price
₹1,192.40
Market cap
₹13,575 Cr
Revenue (annual)
₹2,365 Cr
Net profit (annual)
₹170.1 Cr
P/E (TTM)
77.7×Sector 37.5×
Promoter holding
59.07%+0.00% QoQ
FII holding
7.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Anupam Rasayan India Ltd

All →
23:45 IST NSE
Debt & Borrowing

Anupam Rasayan India Debt & Borrowing

Anupam Rasayan India Limited has allotted non-convertible debt securities. The company filed this disclosure in accordance with SEBI LODR requirements.

23:39 IST BSE
Debt & Borrowing

Anupam Rasayan India Debt & Borrowing: ₹145 Cr

Anupam Rasayan India Ltd allotted 14,500 non-convertible debentures aggregating ₹145 Crore on a private placement basis. The proceeds will be used for debt repayment and corporate purposes.

Value
₹145.0 Cr
21:46 IST BSE
Debt & Borrowing

Anupam Rasayan India Debt & Borrowing: ₹160 Cr

Anupam Rasayan India Ltd. approved the private placement issuance of 16,000 non-convertible debentures (NCDs) aggregating to ₹160 Crore to Aditya Birla Capital Limited.

Value
₹160.0 Cr
From
Aditya Birla Capital Limited
Execution
13 months
20:52 IST BSE
Debt & Borrowing

Anupam Rasayan India Debt & Borrowing: ₹300 Cr

Anupam Rasayan approved a corporate guarantee of up to ₹300 Crore and a share pledge for financing availed by its subsidiary, Mates Visa Consultancy.

Value
₹300.0 Cr
22:38 IST NSE
Board Meeting Date

Anupam Rasayan India Board Meeting Date

Anupam Rasayan India Ltd has scheduled a board meeting for September 19, 2026, to discuss potential fund-raising via a debt issue.

22:28 IST BSE
Board Meeting Date

Anupam Rasayan India Board Meeting Date

Anupam Rasayan India Ltd announced a Board Meeting on September 19, 2026, to consider raising up to ₹160 Crore via non-convertible debentures.

Value
₹160.0 Cr